Loading...
Mixed Asset Passive

RISE Healthcare Fixed Income Balanced (253290)

Update : 2025.10.15

NAV

12,314KRW

-20.65하락 (-0.17%)

Market Price per share (KRW)

12,235KRW

-25하락 (-0.2%)

※ t-1 last price

trading volume

24,259shares

AUM

KRW 14.7billion

RISE Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2025.10.15
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 14,777,203,751
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 12,235
※ t-1 last price
12,314 24,259
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare Fixed Income Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
14,777,203,751 하나은행
Market Price per share (KRW) iNAV per share (KRW)
12,235
※ t-1 last price
12,314
Trading Volume (shares)
24,259
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2025-10-15
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB02625-3003(25-3) 27.06
2 KTB02875-2712(24-12) 20.65
3 RISE HealthCare 12.29
4 RISE KTB 8.46
5 KTB02250-2806(25-4) 6.77
6 원화예금 5.00
7 F 202512 2.89
8 Alteogen 2.11
9 Celltrion 2.04
10 SAMSUNG BIOLOGICS 1.95

proportion by sectors

*The proportion of investment stocks

Update : 2025.10.15
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-06-09 2025-06-11 50
2024-12-09 2024-12-11 90
2024-06-07 2024-06-11 40
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11

Performance

performance

excel download

Update : 2025-10-15

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -1.67 -0.20 3.33 -0.48 23.10 2.86 28.28
Benchmark Index -1.45 0.12 3.85 1.19 27.57 3.77 36.10
Outperformance -0.22 -0.32 -0.52 -1.67 -4.47 -0.92 -7.82

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2025.10.13 12,235 -0.203하락 12,314.34 -0.167하락 10,527.39
2025.10.10 12,260 -0.889하락 12,334.24 -0.288하락 10,516.94
2025.10.02 12,370 -0.080하락 12,367.29 0.240상승 10,512.9
2025.10.01 12,380 0.978상승 12,337.66 0.021상승 10,508.12
2025.09.30 12,260 -0.203하락 12,335.02 -0.242하락 10,512.44
2025.09.29 12,285 0.326상승 12,365.06 0.329상승 10,515.7
2025.09.26 12,245 -0.930하락 12,323.78 -0.685하락 10,516.22
2025.09.25 12,360 -1.592하락 12,408.89 -0.748하락 10,525.38
2025.09.24 12,560 -0.868하락 12,502.52 -0.845하락 10,536.6
2025.09.23 12,670 0.555상승 12,609.15 0.134상승 10,542.2
2025.09.22 12,600 0.278상승 12,592.18 0.623상승 10,541.91
2025.09.19 12,565 0.520상승 12,513.45 0.395상승 10,545.92
2025.09.18 12,500 0.684상승 12,464.2 0.116상승 10,552.98
2025.09.17 12,415 -0.241하락 12,449.65 -0.497하락 10,550.03
2025.09.16 12,445 -0.717하락 12,511.91 -0.020하락 10,547.52
2025.09.15 12,535 0.400상승 12,514.48 -0.078하락 10,541.61

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 KTB02625-3003(25-3) KR103503GF38 666,666,666 27.06 666,406,666
2 KTB02875-2712(24-12) KR103501GEC6 500,000,000 20.65 508,632,000
3 RISE HealthCare KR7253280002 20,641 12.29 302,700,265
4 RISE KTB KR7114100001 1,900 8.46 208,411,000
5 KTB02250-2806(25-4) KR103501GF63 166,666,666 6.77 166,667,665
6 원화예금 KRD010010001 123,088,265 5 123,088,265
7 F 202512 KR4165WC0006 0.67 2.89 71,279,929
8 Alteogen KR7196170005 117 2.11 51,948,000
9 Celltrion KR7068270008 294 2.04 50,244,600
10 SAMSUNG BIOLOGICS KR7207940008 47 1.95 47,940,000
11 Yuhan KR7000100008 392 1.88 46,412,800
12 HLB KR7028300002 822 1.31 32,345,700
13 LCB KR7141080002 184 1.13 27,857,600
14 PharmaResearch KR7214450009 48 1.09 26,832,000
15 ABL Bio KR7298380007 237 0.88 21,685,500
16 SCD KR7000250001 98 0.81 19,894,000
17 SKBP KR7326030004 192 0.8 19,660,800
18 HanmiPharm KR7128940004 44 0.62 15,356,000
19 Hugel KR7145020004 37 0.4 9,916,000
20 HANALL BIOPHARMA KR7009420001 248 0.35 8,556,000
21 SKBS KR7302440003 186 0.35 8,546,700
22 ST Pharm KR7237690003 88 0.34 8,298,400
23 Celltrionph KR7068760008 141 0.3 7,473,000
24 CLASSYS KR7214150005 123 0.24 5,910,150
25 L&C BIO KR7290650001 117 0.24 5,838,300
26 SEEGENE KR7096530001 225 0.22 5,535,000
27 GC Corp KR7006280002 39 0.21 5,050,500
28 Hanmi Science KR7008930000 143 0.21 5,226,650
29 Pharmicell KR7005690003 393 0.2 4,900,710
30 HK inno.N KR7195940002 100 0.19 4,560,000
31 MedyTox KR7086900008 38 0.18 4,529,600
32 CHA Biotech KR7085660009 375 0.17 4,188,750
33 DAEWOONG PHARM KR7069620003 32 0.17 4,284,800
34 Binex KR7053030003 202 0.13 3,284,520
35 DongKook Pharm KR7086450004 165 0.12 3,069,000
36 ShinpoongPharm KR7019170000 232 0.12 2,946,400
37 HLBPHARMA KR7047920004 196 0.11 2,647,960
38 EuBio KR7206650004 219 0.11 2,822,910
39 WONTECH KR7336570007 302 0.11 2,748,200
40 DENTIUM KR7145720009 46 0.1 2,488,600
41 SD Biosensor KR7137310009 245 0.1 2,369,150
42 SELVAS AI KR7108860008 166 0.1 2,358,860
43 BioPlus KR7099430001 291 0.08 1,894,410
44 CUREXO KR7060280005 204 0.08 2,060,400
45 BIONEER KR7064550007 156 0.08 2,068,560
46 Huons Global KR7084110006 38 0.07 1,670,100
47 T&L KR7340570001 32 0.06 1,540,800
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.